Patents by Inventor Andreas Nechansky

Andreas Nechansky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glyco-engineered antibodies
    Patent number: 10253098
    Abstract: The present invention relates to an antibody preparation comprising modified antibodies of an animal or derivatives or fragments thereof, specific for an antigen, characterized in that the antibodies or derivatives or fragments thereof comprise an N-glycan structure free of fucose and xylose, and at least 90%, preferably at least 95%, more preferred at least 99%, most preferred at least 100% of the modified antibodies, derivatives or fragments thereof lack a C-terminal lysine residue.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: April 9, 2019
    Assignee: GREENOVATION BIOTECH GMBH
    Inventors: Manfred Schuster, Ralf Kircheis, Andreas Nechansky, Wolfgang Jost, Gilbert Gorr
  • Glyco-Engineered Antibodies
    Publication number: 20150284461
    Abstract: The present invention relates to an antibody preparation comprising modified antibodies of an animal or derivatives or fragments thereof, specific for an antigen, characterized in that the antibodies or derivatives or fragments thereof comprise an N-glycan structure free of fucose and xylose, and at least 90%, preferably at least 95%, more preferred at least 99%, most preferred at least 100% of the modified antibodies, derivatives or fragments thereof lack a C-terminal lysine residue.
    Type: Application
    Filed: May 28, 2015
    Publication date: October 8, 2015
    Applicant: GREENOVATION BIOTECH GMBH
    Inventors: Manfred Schuster, Ralf Kircheis, Andreas Nechansky, Wolfgang Jost, Gilbert Gorr
  • Glyco-engineered antibodies
    Patent number: 9051577
    Abstract: The present invention relates to an antibody preparation comprising modified antibodies of an animal or derivatives or fragments thereof, specific for an antigen, characterized in that • the antibodies or derivatives or fragments thereof comprise an N-glycan structure free of fucose and xylose, and • at least 90%, preferably at least 95%, more preferred at least 99%, most preferred at least 100% of the modified antibodies, derivatives or fragments thereof lack a C-terminal lysine residue.
    Type: Grant
    Filed: July 11, 2007
    Date of Patent: June 9, 2015
    Assignee: GREENOVATION BIOTECH GMBH
    Inventors: Manfred Schuster, Ralf Kircheis, Andreas Nechansky, Wolfgang Jost, Gilbert Gorr
  • GLYCO-ENGINEERED ANTIBODIES
    Publication number: 20090291078
    Abstract: The present invention relates to an antibody preparation comprising modified antibodies of an animal or derivatives or fragments thereof, specific for an antigen, characterized in that • the antibodies or derivatives or fragments thereof comprise an N-glycan structure free of fucose and xylose, and • at least 90%, preferably at least 95%, more preferred at least 99%, most preferred at least 100% of the modified antibodies, derivatives or fragments thereof lack a C-terminal lysine residue.
    Type: Application
    Filed: July 11, 2007
    Publication date: November 26, 2009
    Applicant: GREENOVATION BIOTECH GMBH
    Inventors: Manfred Schuster, Ralf Kircheis, Andreas Nechansky, Wolfgang Jost, Gilbert Gorr
  • Organic compounds
    Publication number: 20030166568
    Abstract: Screening assay and methods comprising peptide PREKY for the identification of ligands, and ligands identified by such assay, which interfere with cell activation induced via Fc&egr;RI&agr;, e.g. which inhibit mast cell/basophil activation.
    Type: Application
    Filed: December 18, 2002
    Publication date: September 4, 2003
    Inventors: Franz Kricek, Andreas Nechansky, Michael Robertson